Benefits and Risks of Antiretroviral Therapy for Perinatal HIV PreventionMary Glenn Fowler, Lynne Mofenson, Min Qin et al.|New England Journal of Medicine|2016Cited by 348
Antiretroviral Treatment for Children with Peripartum Nevirapine ExposurePaul Palumbo, Avy Violari, Jane C. Lindsey et al.|New England Journal of Medicine|2010Cited by 220
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical TrialPatricia M. Flynn, Taha E. Taha, Mae Cababasay et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2017Cited by 219
Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected ChildrenAvy Violari, Paul Palumbo, Jane C. Lindsey et al.|New England Journal of Medicine|2012Cited by 183
Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum ComponentPatricia M. Flynn, Taha E. Taha, Mae Cababasay et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2021Cited by 63